Cerebral EBV-positive PTLD controlled by PD-1 checkpoint blockade in a liver transplant patient

被引：6

作者：

Bittner, Aitomi ^{[1
,2
,3
,4
]}

Radke, Josefine ^{[2
,3
,4
,5
,6
,7
]}

Eurich, Dennis ^{[2
,3
,4
,8
]}

Wiener, Edzard ^{[9
]}

Denker, Sophy ^{[2
,3
,4
]}

Anagnostopoulos, Ioannis ^{[10
]}

Na, Il-Kang ^{[1
,2
,3
,4
,5
,11
,12
]}

Heppner, Frank L. ^{[2
,3
,4
,5
,7
,13
,14
]}

Bullinger, Lars ^{[1
,2
,3
,4
,5
,6
,7
,15
]}

Schmitt, Clemens A. ^{[1
,2
,3
,4
,6
,15
,16
]}

机构：

[1] Charit Univ Med Berlin, Dept Hematol Oncol & Tumor Immunol, Berlin, Germany

[2] Free Univ Berlin, Berlin, Germany

[3] Humboldt Univ, Berlin, Germany

[4] Berlin Inst Hlth, Berlin, Germany

[5] Berlin Inst Hlth BIH, Berlin, Germany

[6] German Canc Consortium DKTK, Berlin, Germany

[7] Charit Univ Med Berlin, Dept Neuropathol, Berlin, Germany

[8] Charit Univ Med Berlin, Dept Surg, Berlin, Germany

[9] Charit Univ Med Berlin, Inst Neuroradiol, Berlin, Germany

[10] Univ Wurzburg, Inst Pathol, Wurzburg, Germany

[11] Expt & Clin Res Ctr ECRC, Berlin, Germany

[12] BIH Ctr Regenerat Therapies, Berlin, Germany

[13] NeuroCure, Cluster Excellence, Berlin, Germany

[14] German Ctr Neurodegenerat Dis DZNE, Berlin, Germany

[15] Helmholtz Assoc, Max Delbruck Ctr Mol Med, Berlin, Germany

[16] Johannes Kepler Univ Linz, Kepler Univ Hosp, Dept Hematol & Oncol, Linz, Austria

来源：

LEUKEMIA & LYMPHOMA | 2021年 / 62卷 / 08期

关键词：

D O I：

10.1080/10428194.2021.1889537

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：2026 / 2029

页数：4

共 13 条

[1] Checkpoint inhibitor therapy for cancer in solid organ transplantation recipients: an institutional experience and a systematic review of the literature [J].

Abdel-Wahab, Noha ;

Safa, Houssein ;

Abudayyeh, Ala ;

Johnson, Daniel H. ;

Van Anh Trinh ;

Zobniw, Chrystia M. ;

Lin, Heather ;

Wong, Michael K. ;

Abdelrahim, Maen ;

Gaber, A. Osama ;

Suarez-Almazor, Maria E. ;

Diab, Adi .

JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7

[2] Successful Treatment of Disseminated Hepatocellular Carcinoma After Liver Transplantation With Nivolumab [J].

Amjad, Waseem ;

Kotiah, Sandy ;

Gupta, Ankur ;

Morris, Michael ;

Liu, Li ;

Thuluvath, Paul J. .

JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2020, 10 (02) :185-187

[3] Risk factors and incidence of de novo malignancy in liver transplant recipients: a systematic review [J].

Chak, Eric ;

Saab, Sammy .

LIVER INTERNATIONAL, 2010, 30 (09) :1247-1258

[4] Targetable genetic features of primary testicular and primary central nervous system lymphomas [J].

Chapuy, Bjoern ;

Roemer, Margaretha G. M. ;

Stewart, Chip ;

Tan, Yuxiang ;

Abo, Ryan P. ;

Zhang, Liye ;

Dunford, Andrew J. ;

Meredith, David M. ;

Thorner, Aaron R. ;

Jordanova, Ekaterina S. ;

Liu, Gang ;

Feuerhake, Friedrich ;

Ducar, Matthew D. ;

Illerhaus, Gerald ;

Gusenleitner, Daniel ;

Linden, Erica A. ;

Sun, Heather H. ;

Homer, Heather ;

Aono, Miyuki ;

Pinkus, Geraldine S. ;

Ligon, Azra H. ;

Ligon, Keith L. ;

Ferry, Judith A. ;

Freeman, Gordon J. ;

van Hummelen, Paul ;

Golub, Todd R. ;

Getz, Gad ;

Rodig, Scott J. ;

de Jong, Daphne ;

Monti, Stefano ;

Shipp, Margaret A. .

BLOOD, 2016, 127 (07) :869-881

[5] Immune checkpoint inhibitor therapy in solid organ transplant recipients: A patient-centered systematic review [J].

Fisher, Juliya ;

Zeitouni, Nathalie ;

Fan, Weijia ;

Samie, Faramarz H. .

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 82 (06) :1490-1500

[6] Constitutive AP-1 Activity and EBV Infection Induce PD-L1 in Hodgkin Lymphomas and Posttransplant Lymphoproliferative Disorders: Implications for Targeted Therapy [J].

Green, Michael R. ;

Rodig, Scott ;

Juszczynski, Przemyslaw ;

Ouyang, Jing ;

Sinha, Papiya ;

O'Donnell, Evan ;

Neuberg, Donna ;

Shipp, Margaret A. .

CLINICAL CANCER RESEARCH, 2012, 18 (06) :1611-1618

[7] Hallmarks of Cancer: The Next Generation [J].

Hanahan, Douglas ;

Weinberg, Robert A. .

CELL, 2011, 144 (05) :646-674

[8] Liver graft rejection following immune checkpoint inhibitors treatment: a review [J].

Hu, Bo ;

Yang, Xiao-Bo ;

Sang, Xin-Ting .

MEDICAL ONCOLOGY, 2019, 36 (11)

[9] Post-transplant lymphoproliferative disorders following liver transplantation: Incidence, risk factors and survival [J].

Kremers, WK ;

Devarbhavi, HC ;

Wiesner, RH ;

Krom, RAF ;

Macon, WR ;

Habermann, TM .

AMERICAN JOURNAL OF TRANSPLANTATION, 2006, 6 (05) :1017-1024

[10] On being less tolerant: Enhanced cancer immunosurveillance enabled by targeting checkpoints and agonists of T cell activation [J].

Lesokhin, Alexander M. ;

Callahan, Margaret K. ;

Postow, Michael A. ;

Wolchok, Jedd D. .

SCIENCE TRANSLATIONAL MEDICINE, 2015, 7 (280)

← 1 2 →